Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,616 | -44,663 | -22,647 | -75,144 | -55,630 |
| Depreciation Amortization | -1,731 | -1,691 | -985 | 828 | 989 |
| Accounts payable and accrued liabilities | 218 | 719 | 1,694 | -77 | 339 |
| Other Working Capital | -3,080 | -1,815 | -1,414 | -5,961 | -5,065 |
| Other Operating Activity | 10,465 | 7,214 | 2,578 | 9,751 | 6,260 |
| Operating Cash Flow | $-59,744 | $-40,236 | $-20,774 | $-70,603 | $-53,107 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,055 | -928 | -780 | -808 | -692 |
| Purchase Of Investment | -226,750 | -149,367 | -88,965 | -198,453 | -80,203 |
| Sale Of Investment | 212,200 | 112,700 | 44,700 | 74,000 | 58,250 |
| Investing Cash Flow | $-15,605 | $-37,595 | $-45,045 | $-125,261 | $-22,645 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -42 | -29 | -15 | -52 | -39 |
| Common Stock Issued | 9,976 | 87 | 19 | 191,265 | 1,187 |
| Other Financing Activity | -166 | 0 | 0 | -7,142 | -7,142 |
| Financing Cash Flow | $9,768 | $58 | $4 | $184,071 | $-5,994 |
| Beginning Cash Position | 136,925 | 136,925 | 136,925 | 148,718 | 148,718 |
| End Cash Position | 71,344 | 59,152 | 71,110 | 136,925 | 66,972 |
| Net Cash Flow | $-65,581 | $-77,773 | $-65,815 | $-11,793 | $-81,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,744 | -40,236 | -20,774 | -70,603 | -53,107 |
| Capital Expenditure | -1,055 | -928 | -780 | -808 | -692 |
| Free Cash Flow | -60,799 | -41,164 | -21,554 | -71,411 | -53,799 |